| 000 | 01549 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515055013.0 | ||
| 264 | 0 | _c20070504 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a1350-1925 | ||
| 024 | 7 |
_a10.1111/j.1365-2982.2006.00876.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBueno, L | |
| 245 | 0 | 0 |
_aSerotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. _h[electronic resource] |
| 260 |
_bNeurogastroenterology and motility _cJan 2007 |
||
| 300 |
_a89-119 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aGastrointestinal Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aGastrointestinal Tract _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPain Threshold _xdrug effects |
| 650 | 0 | 4 |
_aProbiotics _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aSerotonin Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aVisceral Afferents _xdrug effects |
| 700 | 1 | _ade Ponti, F | |
| 700 | 1 | _aFried, M | |
| 700 | 1 | _aKullak-Ublick, G A | |
| 700 | 1 | _aKwiatek, M A | |
| 700 | 1 | _aPohl, D | |
| 700 | 1 | _aQuigley, E M M | |
| 700 | 1 | _aTack, J | |
| 700 | 1 | _aTalley, N J | |
| 773 | 0 |
_tNeurogastroenterology and motility _gvol. 19 _gno. 1 Suppl _gp. 89-119 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2982.2006.00876.x _zAvailable from publisher's website |
| 999 |
_c16841076 _d16841076 |
||